Skip to search.
 FTSE 100 Up 0.15%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
394.90 Up 3.56(0.91%) 25 Jul 21:00
Prev Close:391.34
Open:391.03
Bid:380.50 x 300
Ask:N/A
1y Target Est:468.05
Beta:1.4697
Next Earnings Date: 4-Aug-16REGN Earnings announcement
Day's Range:387.55 - 395.12
52wk Range:329.09 - 605.93
Volume:386,898
Avg Vol (3m):894,113
Market Cap:41.28b
P/E (ttm):62.61
EPS (ttm):6.31
Div & Yield:N/A (N/A)
Quotes delayed, except where indicated otherwise. Currency in USD.

Comparison

Symbol% ChgMkt Cap
REGNUp 0.91%41.28b
AMGNUp 0.54%125.12b

Key Statistics

Forward P/E (1 yr):25.86
P/S (ttm):9.20
Ex-Dividend Date:N/A

Analysts

Annual EPS Est (Dec-16) :10.78
Quarterly EPS Est (Jun-16) :2.62
Mean Recommendation*:2.2
PEG Ratio (5 yr expected):1.89

* (Strong Buy) 1.0 - 5.0 (Sell)

Analyst Opinion | Estimates

Business Summary

Regeneron Pharmaceuticals, Inc., a biopharmaceutical company, discovers, invents, develops, manufactures, and commercializes medicines for the treatment of serious medical conditions worldwide. more
Your browser doesn't support canvas
SETTINGS
Scrolling
Speed
Display
Price
Submit Feedback